Russell Frank Company’s Ironwood Pharmaceuticals IRWD Stock Holding History

Russell Frank Company’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-9,301	Closed	-$81K	–	3014
2015 Q3	$81K	Sell	9,301 -4,651	-33%	-$43.4K	﹤0.01%	2855
2015 Q2	$141K	Buy	13,952 +12,063	+639%	+$140K	﹤0.01%	2857
2015 Q1	$25K	Hold	1,889	–	–	﹤0.01%	2866
2014 Q4	$24K	Buy	+1,889	New	+$21.6K	﹤0.01%	2860
2013 Q4	–	Sell	-592	Closed	-$6K	–	2919
2013 Q3	$6K	Sell	592 -9,582	-94%	-$94K	﹤0.01%	3308
2013 Q2	$85K	Buy	+10,174	New	+$123K	﹤0.01%	2781

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMC

Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Russell Frank Company's IRWD Position: Q4 2015 in Review

Russell Frank Company sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2015, closing a stake of 9,301 shares — an estimated $81K sold.

Russell Frank Company first reported a position in IRWD in Q2 2013 and held it in 6 quarters. The position peaked at $141K in Q2 2015. 137 funds tracked by Wall St. Rank hold IRWD as of Q4 2015.

Russell Frank Company reported no remaining Ironwood Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Russell Frank Company sold 9,301 Ironwood Pharmaceuticals shares in Q4 2015, an estimated $81K.
Russell Frank Company first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Russell Frank Company's Ironwood Pharmaceuticals position peaked at $141K in Q2 2015.
137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2015.

Based on Russell Frank Company's 13F filing for Q4 2015, filed 27 Jan 2016.